175.908 articles found

Evolutionary analysis of PINK1 reveals key roles of the N- and C-terminal extensions and TOM20 in folding its kinase domain

Shomali T, Veyron S, Trempe J.

· 2026-09-09

DOI: 10.64898/2026.09.05.749644

A scalable model for Parkinson’s disease genetic research in underrepresented populations: lessons from Kyrgyzstan

Shambetova C, Zhunusova E, Ismailova A, Periñan MT, Kiyalbekova S, Gabbert C, Lim S, Djumalieva G, Iliazova A, Beishembieva N, Kubanychbekova A, Kanana Y, Peredereeva E, Metinov A, Sorokin A, Abdumalikova A, Bazarbaeva S, Pakhridinova G, Sattarova B, Upaeva A, Zhamilova G, Zhumadylova E, Mamytova E, Baisalov M, Baitelieva A, Imanalieva J, Bolotalieva A, Toktomametova A, Atambekova N, Baltabaeva S, Dalbaeva A, Osmonova Z, Nurbekova B, Mukhanova A, Tsopova I, Kleinz T, Sverdlova I, Lange LM, Trinh J, Blauwendraat C, Singleton A, Münte TF, Noyce AJ, Kudaibergenova I, Klein C, Global Parkinson’s Genetics Program (GP2).

· 2026-09-09

DOI: 10.64898/2026.09.08.26362411

Reactive Oxygen Species Generation Drives Iron Accumulation by Rotenone-Mediated Inhibition of Mitochondrial Complex I in Dopaminergic Neurons

Abdelrazeq Hassan AS, Pungliya S, Murillo MA, Parry KH, Apfelbaum AR, Grillo AS.

· 2026-09-09

DOI: 10.64898/2026.09.04.749533

Dissociable Handwriting Domains in Parkinson's Disease?

Cetin B, Comoglu S, Ulker A, Onder H.

Movement disorders clinical practice · 2026-09-09

Discovery of Sennoside A as a Natural <i>O</i>-GlcNAcase Inhibitor That Ameliorates Parkinson's Disease by Restoring EphrinB2 <i>O</i>-GlcNAcylation.

Wei G, Jin Z, Mi H, Li N, Wang W, Song Y, Jin Q, Ge G, Liu Y.

Research (Wash D C) · 2026-09-09

DOI: 10.34133/research.1416PMID: 42718897

Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease.

André MM, Morissette M, Bourque M, Rieux M, Soulet D, Di Paolo T.

Front Neurosci · 2026-09-09

DOI: 10.3389/fnins.2026.1870069PMID: 42780212

Brain metabolic and network profiles characterized by comorbid depressive symptoms and sleep disturbances in Parkinson's disease: an <sup>18</sup>F-FDG PET study.

Li K, Bao C, Wang Y, Zhang C, Wu X, Du Y, Shu Y, Fan Y, Quan P, Li Z, He J.

Front Aging Neurosci · 2026-09-09

DOI: 10.3389/fnagi.2026.1901625PMID: 42780300

Robot-assisted gait training for balance, mobility, and gait in Parkinson's disease: a systematic review and meta-analysis.

Zhao Z, Xu C, Li X, Tan Z, Zhang J.

Front Neurol · 2026-09-09

DOI: 10.3389/fneur.2026.1878057PMID: 42780363

Hippocampal subfield diffusion abnormalities in Parkinson's disease with mild cognitive impairment: a volumetric and diffusion MRI study.

Chen Y, Peng L, Hu Q, Zhao Z, Xu B.

Front Aging Neurosci · 2026-09-09

DOI: 10.3389/fnagi.2026.1946629PMID: 42780862

Safety and tolerability of intranasal insulin in Parkinson's disease.

Johnson JC, Kashyap B, Gustafson SK, O'Brien M, Frey WH, Svitak AL, Hanson LR.

Front Neurol · 2026-09-09

DOI: 10.3389/fneur.2026.1875165PMID: 42780868

MIL-O-PD: a two-stage multiple instance learning and heuristic optimization framework for unpaired multimodal Parkinson's diagnosis.

Bera S, Ijaz MF, Choi J, Singh PK.

Front Aging Neurosci · 2026-09-09

DOI: 10.3389/fnagi.2026.1924167PMID: 42780885

Integrating Baduanjin exercise into Parkinson's rehabilitation: a randomized controlled trial.

Kavak MF, Civelek NB, Yalçın G.

Front Aging Neurosci · 2026-09-09

DOI: 10.3389/fnagi.2026.1925159PMID: 42781380